214864.fig.003a
214864.fig.003b
214864.fig.003c
214864.fig.003d
Figure 3: Loss of syndecan-4 staining in aggressive NSGCTs. Tumour cell associated staining and variable stromal staining for syndecan-4 in stage I teratoma/seminoma (a) and stage I embryonal/seminoma (b). Variable stromal staining and loss of tumour cell associated immunoreactivity for syndecan-4 in stage II embryonal/yolk sac (c) and embryonal stage III tumours (d). Scale bar denotes 50 μm.